Although the majority of JAK3 mutations in ALL are located in the JH2 pseudokinase and JH1 kinase domain, the most frequent alteration, JAK3 p.M511I, affects an amino acid right outside the pseudokinase domain [67,89,90,97]. This evidence concerns the gene JAK3 and acute lymphoblastic leukemia.